BioSpace News Archive

Ashland is introducing Klucel™ EXF Ultra HPC, an ultra-fine particle size, premier tablet binder during CPhI North America, April 30 – May 2, 2019 in Chicago.

HealthTap, provider of the world’s most comprehensive, AI-powered virtual primary healthcare, has expanded its offerings to serve employers with significant part-time and contract work forces—individuals who are not covered by traditional employer-provided health insurance.

Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the European Commission (EC) has granted conditional Marketing Authorization for Ondexxya™ (andexanet alfa)

Company’s Research Initiative Recognized as Novel, Innovative Approach to Deliver More Personalized Dialysis Treatment

Haemonetics Corporation announced the election of Claire Pomeroy, M.D., MBA, to its Board of Directors.

Revenue of $200.7 million in the first quarter of 2019 increased 23.1% from revenue of $163.1 million for the comparable prior-year period, representing a backlog conversion rate of 19.0%.

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the first quarter 2019 after market close on Monday, May 6, 2019.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval of a new indication for ERLEADA® (apalutamide) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).

Universal Health Services, Inc. announced that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following conferences

CHOP Clinicians Joined Thousands of Colleagues Worldwide for Annual Conference to Share Latest Research in Pediatrics